Valuation: Medtronic plc

Market Cap 11TCr 9.31TCr 8.59TCr 7.92TCr 15TCr 10,25600Cr 15TCr 1,02700Cr 40TCr 5,02300Cr 40TCr 39TCr 17,29200Cr P/E 2027 *
18.9x
P/E 2028 * 16.4x
Enterprise Value 13TCr 11TCr 10TCr 9.54TCr 18TCr 12,36100Cr 18TCr 1,23700Cr 49TCr 6,05400Cr 48TCr 47TCr 20,84000Cr EV / Sales 2027 *
3.31x
EV / Sales 2028 * 3.14x
Free-Float
99.69%
Yield 2027 *
3.57%
Yield 2028 * 3.76%
1 day-0.43%
1 week-0.80%
Current month+6.35%
1 month+4.87%
3 months-3.47%
6 months-14.01%
Current year-13.39%
1 week 78.97
Extreme 78.97
84.79
1 month 78.14
Extreme 78.14
85.99
Current year 73.31
Extreme 73.31
105.5
1 year 73.31
Extreme 73.31
106.33
3 years 68.84
Extreme 68.84
106.33
5 years 68.84
Extreme 68.84
135.89
10 years 68.84
Extreme 68.84
135.89
Manager TitleAgeSince
Chief Executive Officer 56 27/04/2020
Director of Finance/CFO 56 03/03/2025
Chief Tech/Sci/R&D Officer - 30/09/2025
Director TitleAgeSince
Director/Board Member 67 26/01/2015
Director/Board Member 64 01/01/2013
Director/Board Member 70 01/01/2015
Date Insider Type Main position Quantity % Market Cap.
08/07/26 Sell

Public Communications Manager

-3,102 0.0002%
18/06/26 Other

Executive/Senior Manager

1,60,706 0.0125%
08/06/26 Sell

Executive/Senior Manager

-4,189 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%-0.80%-7.15%-3.93% 11TCr
+1.87%+7.19%-18.59%-5.86% 18TCr
-0.03%+1.47%+5.13%+60.04% 5.99TCr
+0.66%+0.96%+37.64%+54.65% 5.2TCr
-1.10%+4.10%-11.56%-38.29% 4.36TCr
-3.21%-3.05% - - 3.36TCr
-1.71%+2.25%-8.63%-44.43% 2.96TCr
-1.16%+1.28%+69.87%-6.85% 2.53TCr
-1.49%+0.85%-3.43%-4.01% 2.12TCr
-0.91%+1.31%-2.44%-20.78% 2.07TCr
Average -0.75%+1.56%+6.76%-1.05% 5.68TCr
Weighted average by Cap. +0.05%+2.70%-1.64%+2.47%

Financials

2027 *2028 *
Net sales 3.88TCr 3.39TCr 3.13TCr 2.89TCr 5.44TCr 3,74000Cr 5.56TCr 37TCr 15TCr 1,83200Cr 15TCr 14TCr 6,30500Cr 4.02TCr 3.51TCr 3.24TCr 2.99TCr 5.63TCr 3,87000Cr 5.76TCr 39TCr 15TCr 1,89500Cr 15TCr 15TCr 6,52500Cr
Net income 558.45Cr 488.03Cr 450.34Cr 415.1Cr 782.39Cr 54TCr 799.76Cr 5.38TCr 2.12TCr 26TCr 2.1TCr 2.05TCr 91TCr 631.39Cr 551.77Cr 509.16Cr 469.32Cr 884.58Cr 61TCr 904.22Cr 6.09TCr 2.39TCr 30TCr 2.37TCr 2.32TCr 1,02500Cr
Net Debt 2.19TCr 1.91TCr 1.76TCr 1.62TCr 3.06TCr 2,10400Cr 3.13TCr 21TCr 8.28TCr 1,03100Cr 8.21TCr 8.03TCr 3,54800Cr 1.96TCr 1.71TCr 1.58TCr 1.46TCr 2.75TCr 1,88700Cr 2.81TCr 19TCr 7.43TCr 92TCr 7.36TCr 7.2TCr 3,18200Cr
Logo Medtronic plc
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (25%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (19%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (18.1%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - cranial and spinal technologies (14.8%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.7%); - diabetes management (8.2%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.7%): neurostimulation and pumped medication administration products, diagnostic tools, etc. ; - other (0.5%). Net sales are distributed geographically as follows: Ireland (0.3%), the United States (51.2%) and other (48.5%).
Employees
95,000
Date Price Change Volume
17/26/17 $83.20 -0.43% 92,07,621
16/26/16 $83.56 +3.84% 96,98,350
15/26/15 $80.47 +1.48% 87,85,630
14/26/14 $79.30 -5.11% 84,99,354
13/26/13 $83.57 -0.36% 48,85,229
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
83.20USD
Average target price
97.84USD
Spread / Average Target
+17.60%

Quarterly revenue - Rate of surprise